Cargando…
Cardiac FGF23: a new player in myocardial infarction
Fibroblast Growth Factor 23 (FGF23) is a hormone involved in phosphate metabolism. It is known that FGF23 is increased in different pathologies including chronic kidney disease, heart failure or X-linked hypophosphatemia and directly correlates with negative outcome and mortality in severe diseases....
Autores principales: | Schumacher, David, Schuh, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Applied Systems srl
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086082/ https://www.ncbi.nlm.nih.gov/pubmed/32309615 http://dx.doi.org/10.15190/d.2019.10 |
Ejemplares similares
-
A young man with a ST-elevation myocardial infarction
por: Kimman, Jesse R, et al.
Publicado: (2020) -
Phosphate and FGF-23
por: Jüppner, Harald
Publicado: (2011) -
Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease
por: Muñoz-Castañeda, Juan Rafael, et al.
Publicado: (2020) -
FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator?
por: Stöhr, Robert, et al.
Publicado: (2018) -
Coexisting left ventricular aneurysm and pseudoaneurysm after inferior wall myocardial infarction
por: Karaji, Iman, et al.
Publicado: (2020)